Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC — Stella

Home/Nasopharyngeal Carcinoma/IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

View on ClinicalTrials.gov

Recruiting

Back to Nasopharyngeal Carcinoma trials

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

China

Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi

Jiangxi Cancer Hospital, Nanchang, Jiangxi

Key details

Phase

Large-scale testing

Sponsor

Sun Yat-sen University

Enrollment target

~380 participants

Started

January 2024

Primary completion

December 2026

Age range

18 Years – 70 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.